Hsbc Holdings PLC Neogenomics Inc Transaction History
Hsbc Holdings PLC
- $160 Billion
- Q2 2024
A detailed history of Hsbc Holdings PLC transactions in Neogenomics Inc stock. As of the latest transaction made, Hsbc Holdings PLC holds 33,581 shares of NEO stock, worth $491,625. This represents 0.0% of its overall portfolio holdings.
Number of Shares
33,581
Previous 22,849
46.97%
Holding current value
$491,625
Previous $359,000
29.53%
% of portfolio
0.0%
Previous 0.0%
Shares
17 transactions
Others Institutions Holding NEO
# of Institutions
278Shares Held
127MCall Options Held
581KPut Options Held
107K-
Black Rock Inc. New York, NY19.7MShares$288 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.1MShares$207 Million0.0% of portfolio
-
Brown Advisory Inc8.77MShares$128 Million0.16% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD6.73MShares$98.5 Million0.06% of portfolio
-
Janus Henderson Group PLC London, X06.62MShares$96.9 Million0.05% of portfolio
About NEOGENOMICS INC
- Ticker NEO
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 125,796,000
- Market Cap $1.84B
- Description
- NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...